Clik here to view.
Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine...
TOKYO & JERUSALEM Otsuka Pharmaceutical Co., Ltd (Otsuka) and Teva Pharmaceutical Industries, Ltd. (Teva) announce an agreement covering Japan for Otsuka to develop and commercialize Teva’s...
View ArticleClik here to view.
Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of...
VICTORIA, British Columbia Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”) has released its financial results for the first quarter ended March 31, 2017. Amounts,...
View ArticleClik here to view.
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing...
INGELHEIM, Germany & SHANGHAI Today, Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China). The site, with the...
View ArticleClik here to view.
CANbridge and AmoyDx Enter into Strategic Partnership for CAN008 Companion...
BEIJING CANbridge Life Sciences and Amoy Diagnostics announced that they have entered into a strategic partnership to develop a companion diagnostic assay for CANbridge’s lead candidate, CAN008, a...
View ArticleClik here to view.
Radiation Shield Technologies (RST)为迈阿密戴德消防救援局开发Demron...
迈阿密 –(美国商业资讯)–美国陆军预备役兵、国民警卫队、迈阿密戴德消防救援局(MDFRD)、多个地方执法机构及迈阿密港当局开展特定训练合作，以应对大家都不希望发生的特定事件。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿： http://www.businesswire.com/news/home/20170516005937/zh-CN/...
View ArticleClik here to view.
Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients...
MILAN & MORRISTOWN, N.J. Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces USFDA Approval for the Launch of...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received approval from the U.S. Food and Drug Administration...
View ArticleClik here to view.
Sharklet Technologies Announces Acquisition by Peaceful Union and New...
AURORA, Colo. Sharklet Technologies, Inc., a biotechnology company lauded for the creation and commercialization of Sharklet®, the world’s first micro-texture that inhibits bacterial growth on...
View ArticleClik here to view.
GAMA Healthcare Ltd, World Leaders in Infection Control, Acquire Australian...
WATFORD, England Leading infection control specialists, GAMA Healthcare Ltd, acquires the Clinell division of their Australian distributor, AMCLA Pty Ltd., in Victoria. This significant investment...
View ArticleClik here to view.
Avita Medical Announces Positive Results from Pivotal Trial
VALENCIA, Calif. & PERTH, Australia Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today said it achieved both...
View ArticleClik here to view.
Chi-Med Presents Clinical Data at ASCO 2017 Annual Meeting
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that new clinical data on three of its novel tyrosine kinase inhibitors, fruquintinib, savolitinib and...
View ArticleClik here to view.
Sharklet Technologies宣布被Peaceful Union收购，新的伙伴关系将加快应用Sharklet®的医疗器械及表面技术的开发
科罗拉多州奥罗拉 (美国商业资讯) — Sharklet Technologies, Inc.是一家生物技术公司，以发明和商业化Sharklet®而著称，Sharklet®是世界上首款微米织物，可抑制细菌在各类表面上的生长。该公司宣布已完成Peaceful Union领投的一次融资，Peaceful Union是中国杭州的一家医疗器械资产公司。该交易的条款未披露。...
View ArticleClik here to view.
Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced...
View ArticleClik here to view.
FUJIFILM KYOWA KIRIN BIOLOGICS Announces Marketing Authorisation Application...
TOKYO FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President & CEO: Hideaki Nomura; “Fujifilm Kyowa Kirin Biologics”) announces that on May 18, 2017, the European Medicines Agency (EMA) has...
View ArticleClik here to view.
Otsuka Announces Results of Phase 3 Data on Tolvaptan
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces positive top-line results from an additional Phase 3 clinical trial of tolvaptan in adult patients with ADPKD. The primary endpoint of the...
View ArticleClik here to view.
ClearSight Announces Sale of Parent Company, Sharklet Technologies
AURORA, Colo. ClearSight LLC is pleased to announce the acquisition of its parent company Sharklet Technologies, Inc., by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight...
View ArticleClik here to view.
Granules India to Add 102 Jobs, Invest $35 Million in Fairfax County...
FAIRFAX COUNTY, Va. Governor Terry McAuliffe today announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly owned subsidiary,...
View ArticleClik here to view.
Avita Medical’s Board Show Confidence in Company by Taking Payment in Shares
NORTHRIDGE, Calif. & PERTH, Australia & CAMBRIDGE, England The board of pioneering regenerative medicine company Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY), have shown a strong vote of...
View ArticleClik here to view.
CANbridge Life Sciences Raises $25 Million in Series B Round Led by Lapam...
BEIJING CANbridge Life Sciences, a clinical-stage biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it raised $25 million in a Series B...
View ArticleClik here to view.
Dompé Receives Positive CHMP Opinion in Europe For Oxervate® (Cenegermin Eye...
MILAN Today, the biopharmaceutical company Dompé has announced that the Committee for Human Medicinal Products (CHMP) of EMA (European Medicines Agency) has released a positive opinion, recommending...
View Article